Expert Ratings for CVS Health
Portfolio Pulse from Benzinga Insights
CVS Health (NYSE:CVS) has received mostly bullish ratings from analysts in the last quarter, with 13 analysts offering 12-month price targets. The average price target is $90.46, representing an 8.99% decrease from the previous average of $99.40.
September 19, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CVS Health has received mostly bullish ratings from analysts, with an average 12-month price target of $90.46, a decrease from the previous average.
The majority of analysts are bullish on CVS Health, indicating a positive outlook for the company. However, the decrease in the average price target suggests that they expect the stock price to decrease in the future, which could potentially impact the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100